Workflow
浙江康恩贝制药股份有限公司 2024年年度权益分派实施公告

Core Viewpoint - The company has approved a differentiated profit distribution plan for the fiscal year 2024, which includes a cash dividend of 1.50 yuan per 10 shares for eligible shareholders [2][4]. Distribution Plan - The distribution will be based on a total share capital of 2,584,790,946 shares, excluding 63,579,048 shares held in the company's repurchase account, resulting in a base of 2,521,211,898 shares for the cash dividend calculation [2][3]. - The total cash dividend to be distributed amounts to 378,181,784.7 yuan (including tax) [2]. Dividend Calculation - The cash dividend per share is calculated to be approximately 0.1463 yuan after adjusting for the total share capital [3][5]. - The reference price for ex-dividend trading will be adjusted based on the formula provided, taking into account the cash dividend and the change in circulating shares [5]. Implementation Method - Cash dividends will be distributed through the China Securities Depository and Clearing Corporation Limited Shanghai Branch to registered shareholders as of the record date [5][6]. - Shareholders who have not completed designated transactions will have their dividends held by the clearing company until the transactions are completed [5]. Taxation Information - Individual shareholders holding shares for over one year will be exempt from personal income tax on dividends, while those holding for less than one month will have their dividends fully taxed [7][8]. - Qualified Foreign Institutional Investors (QFIIs) will have a 10% withholding tax applied, resulting in a net cash dividend of 0.135 yuan per share [8][9]. Future Adjustments - Following the completion of the 2024 profit distribution, the company will adjust the exercise price of its stock option incentive plan in accordance with regulatory requirements [10].